Home » Topics » BioWorld Science

BioWorld Science
RSS

TRPV1 as a novel therapeutic target in type 2 diabetes mellitus

Aug. 19, 2019

Integrin alphaVbeta6 found to be an effective target for pancreatic ductal adenocarcinoma therapy

Aug. 19, 2019

IKK-alpha and BRAF kinases implicated in DNA damage response can be targeted in cancer

Aug. 19, 2019

In dopamine D1 receptor combo, ghrelin is resurrected as Alzheimer's target

Aug. 16, 2019

Soligenix awarded grant to evaluate SGX-942 in pediatric indications

Aug. 16, 2019

CytoDyn provides update on its HIV dose-escalating monotherapy trial of leronlimab

Aug. 16, 2019

Helmholtz Zentrum Munchen, Phio to identify new targets based on sd-rxRNA platform

Aug. 16, 2019

CARB-X awards funding to IBT to expand development of its IBT-V02 vaccine

Aug. 16, 2019

Rozlytrek approved by FDA or two new cancer indications

Aug. 16, 2019

FDA approves new drug combination for highly drug-resistant tuberculosis

Aug. 16, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...